Bryn Mawr Trust »

Genes shares owned by Bryn Mawr Trust

Quarter-by-quarter ownership of Genes (GCO) shares owned by Bryn Mawr Trust from 13F filings

Historical chart of Bryn Mawr Trust investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Bryn Mawr Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Bryn Mawr Trust

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.9k 67 42.75

More positions owned by Bryn Mawr Trust

Comcast Corp Cl A (CMCSA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Rus Tp200 Gr Etf (IWY)
Ishares Tr Core S&p500 Etf (IVV)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Procter & Gamble Company (PG)

View all positions for Bryn Mawr Trust

Top funds holding Genes

Pzena Investment Management
Fund 1 Investments
BlackRock
Vanguard Group
Dimensional Fund Advisors
Acadian Asset Management
Morgan Stanley
Nomura Holdings
D. E. Shaw & Co
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Geode Capital Management
ING Groep
Healthcare Of Ontario Pension Plan Trust Fund

View all funds holding Genes